RYTM
Rhythm Pharmaceuticals Inc
92.80$
-0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.1% | -22.3% | +47.6% | -4.8% | +7.9% | -1.4% | -3.6% | +36.0% | -5.3% | -7.9% | -1.1% | |
| – | -6.4% | -23.5% | +51.6% | -4.8% | +9.9% | -1.3% | -2.3% | +37.2% | -5.6% | -7.9% | -0.8% | |
| – | -7.0% | -11.1% | +202.6% | -70.6% | +87.6% | +19.0% | +27.8% | -61.6% | +4.3% | +14.4% | +5.6% | |
| – | -7.8% | -27.1% | +58.6% | -6.5% | +7.4% | -1.9% | -7.5% | +43.0% | -6.5% | -12.4% | -2.9% | |
| – | +2.2% | -1.2% | +19.8% | +9.7% | -4.1% | -3.7% | +46.5% | +26.5% | -21.0% | +31.1% | +18.2% | |
| – | +11.1% | -1.4% | +41.0% | +15.8% | +34.9% | +3.1% | -2.3% | +17.1% | +16.5% | +11.3% | +6.5% | |
| – | -3.0% | -3.0% | -3.1% | -3.2% | -3.4% | -3.5% | -3.6% | -3.7% | -3.9% | -4.0% | -4.2% | |
| – | +4.0% | +20.9% | +2.7% | +4.2% | +8.0% | -1.8% | +7.0% | -11.7% | -0.5% | -2.6% | +7.5% | |
| – | +10.1% | -1.9% | +1.0% | +78.4% | +18.4% | -3.2% | +15.8% | -19.5% | +1.6% | -2.6% | +19.8% | |
| – | +2.9% | +3.0% | +2.9% | – | – | – | +127.7% | +22.4% | +4.2% | +4.0% | +4.0% | |
| – | +27.2% | +54.6% | -39.8% | +7.6% | +152.3% | -3.4% | +34.2% | -14.7% | +2.3% | -11.8% | +31.4% | |
| – | -14.0% | -63.7% | +191.5% | -14.9% | +7.8% | -0.9% | -18.1% | +121.3% | -8.7% | -12.0% | -8.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.3% | +1.6% | +1.4% | +0.3% | +0.6% | +2.4% | +1.0% | +1.0% | +3.9% | +1.6% | +0.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.